| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Enochian Biosciences Inc (NASDAQ: ENOB)
ENOB Technical Analysis
5
| As on 9th Jun 2023 ENOB STOCK Price closed @ 0.73 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.46 & Strong Sell for SHORT-TERM with Stoploss of 6.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENOBSTOCK Price
| Open | 0.75 | Change | Price | % |
| High | 0.78 | 1 Day | -0.01 | -1.35 |
| Low | 0.71 | 1 Week | -0.17 | -18.89 |
| Close | 0.73 | 1 Month | -0.48 | -39.67 |
| Volume | 66516 | 1 Year | -7.51 | -91.14 |
| 52 Week High 9.00 | 52 Week Low 0.73 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ENOB Daily Charts |
ENOB Intraday Charts |
Whats New @ Bazaartrend |
ENOB Free Analysis |
|
|
ENOB Important Levels Intraday
| RESISTANCE | 0.86 |
| RESISTANCE | 0.82 |
| RESISTANCE | 0.79 |
| RESISTANCE | 0.77 |
| SUPPORT | 0.69 |
| SUPPORT | 0.67 |
| SUPPORT | 0.64 |
| SUPPORT | 0.60 |
ENOB Forecast May 2024
| 4th UP Forecast | 9.69 |
| 3rd UP Forecast | 6.82 |
| 2nd UP Forecast | 5.04 |
| 1st UP Forecast | 3.26 |
| 1st DOWN Forecast | -1.8 |
| 2nd DOWN Forecast | -3.58 |
| 3rd DOWN Forecast | -5.36 |
| 4th DOWN Forecast | -8.23 |
ENOB Weekly Forecast
| 4th UP Forecast | 3.04 |
| 3rd UP Forecast | 2.30 |
| 2nd UP Forecast | 1.84 |
| 1st UP Forecast | 1.38 |
| 1st DOWN Forecast | 0.08 |
| 2nd DOWN Forecast | -0.38 |
| 3rd DOWN Forecast | -0.84 |
| 4th DOWN Forecast | -1.58 |
ENOB Forecast2024
| 4th UP Forecast | 17.17 |
| 3rd UP Forecast | 11.9 |
| 2nd UP Forecast | 8.64 |
| 1st UP Forecast | 5.38 |
| 1st DOWN Forecast | -3.92 |
| 2nd DOWN Forecast | -7.18 |
| 3rd DOWN Forecast | -10.44 |
| 4th DOWN Forecast | -15.71 |
Enochian Biosciences Inc ( NASDAQ USA Symbol : ENOB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENOB Business Profile
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California. Address: Century City Medical Plaza, Los Angeles, CA, United States, 90067-2012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service